angiotensinconvert
enzym
recent
identifi
member
reninangiotensin
system
ra
degrad
angiotensin
ang
ii
seven
amino
acid
peptid
fragment
ang
homologu
angiotensinconvert
enzym
ace
block
ace
inhibitor
although
found
mani
tissu
express
especi
high
kidney
particularli
within
cell
proxim
tubul
mice
delet
gene
associ
develop
latestag
glomerulosclerosi
acceler
diabet
nephropathi
absenc
hypertens
spontan
hypertens
rat
administr
human
recombin
reduc
blood
pressur
diabet
mice
exogen
human
diminish
blood
pressur
glomerular
injuri
thu
may
endogen
protector
progress
chronic
kidney
diseas
ckd
kidney
tubular
epitheli
cell
local
apic
membran
also
appear
cytoplasm
shed
carboxyterminu
plasma
membran
cultur
human
embryon
kidney
cell
airway
epitheli
cell
process
catalyz
enzym
disintegrin
whether
process
occur
proxim
tubul
unclear
although
solubl
detect
human
urin
recent
studi
urinari
level
protein
significantli
increas
human
ckd
major
chronic
glomerulonephr
compar
healthi
control
determin
enzymelink
immunosorb
assay
elisa
urinari
also
higher
diabet
ckd
result
suggest
may
shed
urin
could
biomark
ckd
patient
howev
presenc
urinari
studi
renal
transplant
recipi
factor
associ
elev
urinari
remain
unclear
accordingli
principl
object
present
studi
determin
urinari
activ
protein
mrna
detect
renal
transplant
patient
identifi
factor
associ
presenc
addit
examin
factor
associ
urinari
ace
activ
protein
mrna
patient
data
indic
urinari
increas
renal
transplant
recipi
diabet
possibl
due
increas
shed
tubular
cell
studi
involv
recruit
human
subject
describ
written
inform
consent
studi
conduct
accord
principl
express
declar
helsinki
studi
protocol
approv
research
ethic
board
ottawa
hospit
protocol
number
subject
studi
healthi
control
age
yr
recruit
hospit
research
centr
staff
histori
kidney
diseas
hypertens
diabet
renal
transplant
recipi
ottawa
hospit
renal
transplant
program
age
yr
month
posttranspl
time
enrol
half
transplant
subject
n
also
enrol
ongo
random
control
trial
determin
effect
ace
inhibitor
ramipril
transplant
outcom
ace
inhibit
preserv
renal
function
surviv
kidney
transplant
intern
standard
random
control
trial
number
registri
yet
receiv
either
placebo
ramipril
subject
document
signific
proteinuria
mg
urinari
proteinday
baselin
transplant
recipi
patient
without
signific
proteinuria
spot
urin
acr
normal
rang
mg
proteinuriaday
subject
exclud
take
ace
inhibitor
angiotensin
receptor
antagonist
renin
inhibitor
pregnant
current
urinari
tract
infect
obtain
inform
consent
spot
urin
sampl
collect
subject
blood
sampl
drawn
measur
serum
creatinin
cr
determin
estim
glomerular
filtrat
rate
egfr
use
modif
diet
renal
diseas
mdrd
calcul
demograph
inform
obtain
via
interview
subject
andor
hospit
chart
transplant
recipi
diagnosi
diabet
mellitu
primari
renal
diagnos
obtain
directli
survey
hospit
chart
urin
sampl
place
ice
aliquot
centrifug
g
min
measur
urinari
albumin
perform
supernat
fraction
use
elisa
kit
exocel
inc
philadelphia
pa
usa
result
correct
urinari
cr
concentr
use
kit
specif
human
cr
creatinin
companion
exocel
inc
enzym
activ
urinari
ace
measur
use
synthet
substrat
essenti
previous
report
result
correct
cr
concentr
urin
sampl
detail
assay
found
text
amount
present
urin
specimen
quantifi
use
commerci
elisa
kit
cat
adipogen
seoul
korea
accord
protocol
provid
supplier
http
standard
curv
gener
perform
serial
dilut
human
recombin
ngml
provid
kit
limit
detect
rang
ngml
preliminari
experi
averag
intraassay
coeffici
variat
cv
assay
averag
interassay
cv
valu
n
amount
obtain
elisa
normal
subject
urin
cr
concentr
report
ngmg
cr
urin
aliquot
supernat
fraction
subject
immunoblot
analysi
ace
use
commerci
avail
antibodi
control
variat
urin
concentr
valu
obtain
densitometri
divid
correspond
cr
concentr
urin
sampl
detail
assay
found
text
urin
aliquot
supernat
fraction
subject
deglycosyl
reaction
use
pngase
f
cat
new
england
biolab
ipswich
usa
deglycosyl
urinari
protein
fragment
detect
western
analysi
detail
assay
found
text
urin
sampl
ml
centrifug
g
min
total
rna
isol
pellet
fraction
subject
realtim
rtpcr
quantit
ace
see
text
assay
detail
urinari
level
ang
ii
measur
use
commerci
peptid
radioimmunoassay
ria
kit
contain
ang
iiselect
polyclon
antibodi
ii
peninsula
laboratori
san
carlo
ca
usa
essenti
describ
ang
level
measur
use
commerci
peptid
enzym
immunoassay
eia
kit
contain
ang
select
polyclon
antibodi
peninsula
laboratori
assay
detail
see
text
data
present
visual
box
plot
continu
variabl
report
median
valu
interquartil
rang
parenthes
statist
analysi
perform
nonparametr
mannwhitney
u
test
unpair
sampl
compar
data
healthi
control
transplant
recipi
diabet
vs
nondiabet
transplant
recipi
linear
regress
model
construct
identifi
potenti
explanatori
variabl
urinari
ace
level
transplant
subject
depend
variabl
measur
studi
eg
activ
follow
explanatori
variabl
enter
model
age
gender
diabet
egfr
albuminuria
hypertens
use
calcineurin
inhibitor
variabl
forc
simultan
remov
model
statist
signific
standard
regress
coeffici
present
depend
variabl
model
data
analyz
use
sigmastat
version
systat
jmp
version
sa
inc
data
p
valu
consid
signific
characterist
healthi
control
transplant
subject
depict
tabl
median
age
control
subject
interquartil
rang
iqr
yr
male
median
age
transplant
subject
iqr
yr
male
diabet
hypertens
median
time
transplant
iqr
yr
median
egfr
iqr
control
subject
iqr
transplant
subject
median
albuminuria
level
iqr
mgmmol
cr
control
subject
iqr
mgmmol
cr
transplant
subject
transplant
patient
tripl
immunosuppress
therapi
compris
prednison
calcineurin
inhibitor
tacrolimu
cyclosporin
either
azathioprin
mycophenol
mofetil
shown
figur
urinari
activ
significantli
increas
transplant
patient
compar
control
subject
control
median
iqr
ngeqmg
vs
transplant
median
iqr
ngeqmg
p
similarli
urinari
protein
elisa
significantli
increas
transplant
patient
compar
control
figur
control
median
iqr
ngmg
cr
vs
transplant
median
iqr
ngmg
cr
p
unconcentr
urin
sampl
control
transplant
subject
identifi
western
analysi
protein
doublet
kda
kda
urinari
activ
elisa
measur
western
analys
reveal
signific
increas
urinari
protein
transplant
patient
compar
control
figur
p
within
group
transplant
patient
multipl
linear
regress
use
primari
renal
diseas
explanatori
variabl
reveal
signific
associ
diagnosi
diabet
nephropathi
n
urinari
protein
elisa
western
analys
p
contrast
signific
associ
urinari
level
primari
caus
renal
diseas
patient
studi
perform
associ
diabet
mellitu
urinari
transplant
patient
transplant
patient
diagnosi
diabet
mellitu
list
hospit
chart
major
patient
take
insulin
take
oral
hypoglycem
agent
patient
dietari
therapi
alon
transplant
patient
diabet
n
significantli
higher
level
urinari
activ
compar
nondiabet
n
subject
figur
diabet
iqr
vs
nondiabet
iqr
ngeqmg
p
similarli
protein
level
elisa
western
analysi
significantli
increas
diabet
subject
compar
nondiabet
figur
c
p
vs
nondiabet
transplant
patient
diabet
kda
kda
protein
band
significantli
increas
western
compar
nondiabet
p
vs
nondiabet
kda
band
p
vs
nondiabet
kda
band
moreov
urinari
protein
level
elisa
significantli
increas
subject
diabet
pretranspl
n
compar
subject
develop
diabet
transplant
n
p
state
glycosyl
urinari
protein
kda
kda
studi
treat
urin
sampl
deglycosylas
enzym
pngase
f
urinari
fragment
size
reduc
kda
kda
pngase
f
treatment
indic
fragment
origin
glycosyl
figur
rna
extract
urinari
pellet
subject
realtim
pcr
mrna
detect
urin
sampl
transplant
patient
signific
differ
diabet
iqr
pg
mrnamg
nondiabet
subject
iqr
pg
mrnamg
p
adjust
potenti
confound
factor
age
gender
diabet
egfr
albuminuria
hypertens
use
calcineurin
inhibitor
diabet
significantli
associ
urinari
activ
p
protein
level
p
tabl
transplant
patient
increas
urinari
acr
associ
urinari
protein
elisa
p
activ
protein
western
femal
gender
associ
higher
urinari
mrna
level
transplant
patient
p
tabl
sinc
number
patient
take
calcineurin
inhibitor
patient
highli
skew
tabl
multivari
analysi
also
perform
exclus
variabl
alter
signific
level
paramet
report
tabl
urinari
ace
activ
detect
transplant
patient
median
patient
iqr
ngeqmg
western
analysi
ace
detect
urin
sampl
transplant
patient
protein
band
approxim
kda
consist
previou
studi
figur
urinari
ace
activ
protein
level
significantli
increas
diabet
transplant
subject
compar
nondiabet
patient
figur
b
p
p
respect
ace
mrna
detect
urin
sampl
transplant
patient
signific
differ
diabet
iqr
pg
mrnamg
nondiabet
patient
iqr
pg
mrnamg
p
adjust
potenti
confound
variabl
increas
urinari
albumincr
associ
urinari
ace
protein
western
analysi
transplant
patient
p
tabl
howev
diabet
associ
increas
urinari
ace
activ
ace
protein
femal
gender
urinari
albumincr
significantli
associ
increas
urinari
ace
mrna
level
transplant
patient
tabl
transplant
patient
diabet
significantli
higher
level
urinari
ang
ii
compar
nondiabet
figur
p
urinari
ang
level
differ
two
group
figur
p
howev
signific
posit
linear
correl
found
urinari
activ
urinari
ang
r
p
multivari
analysi
diabet
remain
significantli
associ
urinari
ang
ii
level
p
tabl
neither
diabet
clinic
factor
egfr
urinari
albumincr
etc
associ
urinari
ang
level
multipl
linear
regress
model
major
find
studi
urinari
activ
protein
increas
kidney
transplant
recipi
compar
healthi
control
subject
presenc
diabet
strongli
associ
urinari
level
patient
popul
multivari
analysi
femal
gender
associ
significantli
urinari
mrna
ace
mrna
level
detect
transplant
recipi
respect
express
rel
high
level
kidney
particularli
proxim
tubul
thought
renoprotect
via
abil
reduc
ang
ii
level
also
increas
product
ang
oppos
deleteri
nonhemodynam
action
ang
ii
tubular
cell
kidney
express
reduc
experiment
model
includ
remnant
kidney
model
ckd
human
diabet
nephropathi
express
decreas
glomeruli
proxim
tubul
suggest
predisposit
ang
iimedi
injuri
result
support
hypothesi
transplant
patient
diabet
exhibit
increas
urinari
excret
protein
independ
egfr
determin
multivari
analysi
solubl
ace
detect
human
urin
human
ckd
mizuiri
et
al
report
increas
urinari
level
protein
elisa
compar
healthi
subject
patient
diabet
nephropathi
higher
urinari
level
without
diabet
nephropathi
use
ace
inhibitor
andor
angiotensin
receptor
blocker
affect
urinari
level
studi
subject
take
inhibitor
ra
use
three
independ
assay
urinari
enzym
activ
elisa
immunoblot
multipl
linear
regress
reveal
diabet
variabl
consist
predict
higher
urinari
level
age
gender
influenc
urinari
activ
protein
level
similarli
patient
ckd
mizuiri
et
al
found
differ
urinari
level
male
femal
although
gender
influenc
urinari
activ
protein
present
studi
femal
significantli
higher
urinari
mrna
level
gene
locat
x
chromosom
rat
renal
wrap
model
hypertens
intraren
activ
express
upregul
estrogen
rais
possibl
femal
transplant
recipi
may
express
mrna
higher
level
kidney
compar
male
femal
gender
also
associ
higher
urinari
ace
mrna
level
albuminuria
latter
agreement
studi
patient
diabet
nephropathi
cellular
origin
urinari
mrna
ace
unknown
although
specul
proxim
tubular
cell
may
sourc
sinc
express
compon
ra
found
urin
sediment
howev
physiolog
signific
urinari
ace
mrna
level
unclear
regard
diabet
albuminuria
egfr
influenc
urinari
mrna
level
transplant
recipi
result
differ
diabet
nephropathi
patient
proteinuria
found
correl
posit
urinari
mrna
egfr
correl
neg
mrna
factor
relat
transplant
could
therefor
independ
influenc
urinari
mrna
one
possibl
use
immunosuppress
drug
transplant
subject
might
regul
shed
cell
express
mrna
urin
urinari
protein
could
origin
least
partli
plasma
via
filtrat
glomerulu
could
deriv
via
excret
renal
cell
although
mizuiri
et
al
found
higher
urinari
level
ckd
patient
differ
plasma
protein
ckd
patient
healthi
subject
howev
ckd
patient
studi
signific
albuminuria
suggest
may
leak
urin
across
glomerular
barrier
present
studi
found
associ
albuminuria
either
urinari
activ
protein
level
western
analysi
data
suggest
urinari
protein
like
deriv
via
shed
cell
along
nephron
filtrat
plasma
support
hypothesi
solubl
shed
plasma
membran
cell
cultur
system
via
cleavag
ectodomain
proteas
enzym
interestingli
renal
upregul
ang
iiinduc
kidney
injuri
de
novo
express
occur
human
kidney
diseas
proxim
tubul
podocyt
mesangi
cell
whether
activ
transplant
kidney
presenc
diabet
mediat
shed
solubl
urin
requir
studi
two
band
detect
immunoblot
urin
sampl
current
studi
one
band
found
kda
consist
fulllength
protein
kda
like
cleav
fragment
thu
kda
fragment
simpli
repres
deglycosyl
form
fulllength
sinc
incub
pngase
f
result
reduct
size
shown
figur
determin
kda
fragment
gener
cleavag
character
requir
includ
use
antibodi
direct
cytoplasm
carboxyterminu
may
lack
fragment
andor
direct
sequenc
analysi
polypeptid
furthermor
although
shed
fragment
may
occur
via
transplant
subject
proteom
analysi
identifi
one
protein
present
urinari
exosom
isol
human
urin
suggest
membranebound
fulllength
may
also
sourc
urinari
multivari
analysi
diabet
significantli
associ
urinari
ang
ii
level
transplant
subject
consist
intraren
ra
activ
diabet
regard
although
diabet
patient
significantli
higher
urinari
ace
activ
ace
protein
level
immunoblot
associ
confirm
multivari
analysi
final
although
diabet
higher
urinari
activ
protein
level
signific
associ
diabet
urinari
level
ang
multivari
analysi
suggest
urinari
ang
may
influenc
factor
potenti
limit
urinari
angiotensin
peptid
measur
urin
specimen
treat
proteas
inhibitor
could
affect
sensit
detect
differ
interestingli
howev
observ
signific
correl
urinari
activ
ang
level
studi
number
strength
includ
reliabl
reproduc
assay
inclus
data
mrna
protein
product
use
multipl
linear
regress
adjust
confound
variabl
limit
includ
rel
small
number
subject
absenc
plasma
ace
measur
singl
time
point
urinari
ace
peptid
assay
furthermor
possibl
diabet
alon
may
contribut
increas
urinari
level
independ
transplant
statu
studi
patient
diabet
normal
kidney
function
requir
answer
question
larger
studi
also
need
determin
urinari
ace
biomark
transplant
function
may
predict
respons
blockad
ra
summari
renal
transplant
recipi
diabet
strong
independ
predictor
increas
urinari
level
activ
protein
data
suggest
may
shed
urin
transplant
recipi
could
repres
marker
assess
role
kidney
ra
patient
